ArticleACS biomaterials science & engineering2025
Fabrication of Multiscale, Multidirectional Orientated Collagen Hydrogels with Guided Cell Alignment Using Fluidics and a Three-Dimensional Printing.
Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Step-Ladder Bioprinting to Align Collagen Fibers for Anisotropic Tissue Fabrication.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration.Advanced healthcare materials · 2026Review
- Collagen Fibril Orientation In Vitro: From Formation to Advanced Biomaterial Development.Biomimetics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various tissues have oriented collagen structures that confer mechanical strength and stability. However, creating models that precisely mimic the size and direction of these tissues remains challenging. In the present study, we developed a collagen tissue with multiscale and multidirectional controlled orientation using fluidic devices prepared using three-dimensional (3D) printing technology. Two types of fluidic channels were fabricated: a one-directional "horizontal orientation model" and vertical protrusions added to create a two-directional "vertical/horizontal orientation model". A type I collagen solution, mixed with or without cells, was introduced into the fluidic channel and gelled. As a result, in the horizontal orientation model, collagen fibrils and fibers were oriented by the flow. Both the fibroblasts and stem cells were aligned parallel to the flow along the collagen structure. In the vertical/horizontal orientation model, both the horizontal and vertical parts confirmed the orientation of collagen fibrils, fibers, and fibroblasts in both directions. Observation of the model at the nanoscale level using scanning electron microscopy (SEM) can explain the collagen orientation mechanism at the molecular and fibril levels. Prior to full gelation, collagen molecules and fibrils align parallel to the flow owing to the influence of flow and channel wall effects. This wall effect, starting from the outer channel wall, creates a gelated collagen "wall" toward the inside of the channel. Collagen fibrils aggregate into collagen fibers. In our experiments focusing on collagen contraction, the cell orientation was also described. As cells proliferate in response to the contact guidance of collagen fibrils and fiber orientation, focal adhesions and F-actin are activated and organize anisotropic traction forces that, in turn, drive cell orientation. Therefore, our method enables the customization of models with the desired tissue-specific orientations, thereby advancing future possibilities in tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.